✦ LIBER ✦

804 SUSTAINED VIROLOGIC RESPONSE AFTER PEGINTERFERON ALFA-2B AND RIBAVIRIN TREATMENT PREDICTS LONG-TERM CLEARANCE OF HCV AT 5-YEAR FOLLOW-UP

✍ Scribed by M. Manns; K.L. Lindsay; S.C. Gordon; P.J. Pockros; D. Haeussinger; S. Hadziyiannis; W. Schmidt; I. Jacobson; R. Barcena; E. Schiff; O.S. Shaikh; B. Bacon; P. Marcellin; C. Smith; J.G. McHutchison; W. Deng; L.D. Pedicone; J.K. Albrecht

Book ID: 117376730
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 55 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60806-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

800 SUSTAINED VIROLOGIC RESPONSE TO INTE

800 SUSTAINED VIROLOGIC RESPONSE TO INTERFERON ALFA-2B PLUS RIBAVIRIN PREDICTS LONG-TERM CLEARANCE OF HCV IN PEDIATRIC PATIENTS AT 5 YEAR FOLLOW-UP

✍ D. Kelly; B. Haber; R.P. Gonzalez-Peralta; K.F. Murray; M.M. Jonas; J.P. Mollest 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

S1001 Clearance of HCV At 5 Year Follow-

S1001 Clearance of HCV At 5 Year Follow-Up for Peginterferon Alfa-2b ± Ribavirin Is Predicted By Sustained Virologic Response At 24 Weeks Post Treatment

✍ Lindsay, Karen; Manns, Michael P.; Gordon, Stuart C.; Pockros, Paul; Haussinger, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 97 KB

744 Sustained virologic response (SVR) t

744 Sustained virologic response (SVR) to interferon-alpha-2b +/- ribavirin therapy at 6 months reliably predicts long-term clearance of HCV at 5-year follow-up

✍ J.G. McHutchison; M.L. Shiffman; S.C. Gordon; K.L. Lindsay; T. Morgan; G. Norkra 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 115 KB

S1004 Clearance of HCV in Children At 5-

S1004 Clearance of HCV in Children At 5-Year Follow-Up Is Predicted By Sustained Virologic Response At 24 Weeks Post Treatment with Interferon Alfa-2b Plus Ribavirin

✍ Kelly, Deirdre; Haber, Barbara; Gonzalez-Peralta, Regino P.; Murray, Karen F.; J 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 112 KB

527 SUSTAINED HCV CLEARANCE AND INCREASE

527 SUSTAINED HCV CLEARANCE AND INCREASED HBSAG SEROCLEARANCE IN PATIENTS WITH DUAL CHRONIC HEPATITIS C AND B POST-PEGINTERFERON ALFA-2A AND RIBAVIRIN TREATMENT: A 5-YEAR FOLLOW-UP

✍ C.-J. Liu; W.-L. Chuang; C.-M. Lee; M.-L. Yu; S.-N. Lu; S.-S. Wu; L.-Y. Liao; C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Mutation frequency of NS5A in patients v

Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy

✍ A. C. W. Jenke; S. Moser; V. Orth; M. Zilbauer; P. Gerner; S. Wirth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB